SPY386.54-3.04 -0.78%
DIA314.19-1.40 -0.44%
IXIC13,358.79-230.04 -1.69%

Regeneron Pharmaceuticals Q4 Adj. EPS $9.53 Beats $8.39 Estimate, Sales $2.42B Inline

Regeneron Pharmaceuticals (NASDAQ:REGN) reported quarterly earnings of $9.53 per share which beat the analyst consensus estimate of $8.39 by 13.59 percent. This is a 27.07 percent increase over earnings of $7.50 per

· 02/05/2021 06:31
Regeneron Pharmaceuticals (NASDAQ:REGN) reported quarterly earnings of $9.53 per share which beat the analyst consensus estimate of $8.39 by 13.59 percent. This is a 27.07 percent increase over earnings of $7.50 per share from the same period last year. The company reported quarterly sales of $2.42 billion which met the analyst consensus estimate. This is a 11.52 percent increase over sales of $2.17 billion the same period last year.